Immunotherapy and Radiotherapy Combinations for Sarcoma

被引:2
作者
Zhang, Qian S. [1 ]
Hayes, John P. [1 ]
Gondi, Vinai [1 ]
Pollack, Seth M. [2 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Radiat Oncol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Oncol, 303 E Super St 3-115, Chicago, IL 60611 USA
关键词
SOFT-TISSUE SARCOMA; ADJUVANT RADIATION-THERAPY; OPEN-LABEL; T-CELLS; CHECKPOINT BLOCKADE; METASTATIC SARCOMA; ANTITUMOR-ACTIVITY; IMMUNE-MECHANISMS; LOCAL RADIATION; BREAST-CANCER;
D O I
10.1016/j.semradonc.2023.12.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sarcomas are a heterogeneous group of bone and soft tissue tumors. Survival outcomes for advanced (unresectable or metastatic) disease remain poor, so therapeutic improvements are needed. Radiotherapy plays an integral role in the neoadjuvant and adjuvant treatment of localized disease as well as in the treatment of metastatic disease. Combining radiotherapy with immunotherapy to potentiate immunotherapy has been used in a variety of cancers other than sarcoma, and there is opportunity to further investigate combining immunotherapy with radiotherapy to try to improve outcomes in sarcoma. In this review, we describe the diversity of the tumor immune microenvironments for sarcomas and describe the immunomodulatory effects of radiotherapy. We discuss studies on the timing of radiotherapy relative to immunotherapy and studies on the radiotherapy dose and fractionation regimen to be used in combination with immunotherapy. We describe the impact of radiotherapy on the tumor immune microenvironment. We review completed and ongoing clinical trials combining radiotherapy with immunotherapy for sarcoma and propose future directions for studies combining immunotherapy with radiotherapy in the treatment of sarcoma. Semin Radiat Oncol 34:229 -242 (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:229 / 242
页数:14
相关论文
共 132 条
[91]   Combined Immune Checkpoint Blockade and Radiation Therapy: Timing and Dose Fractionation Associated with Greatest Survival Duration Among Over 750 Treated Patients [J].
Samstein, R. ;
Rimner, A. ;
Barker, C. A. ;
Yamada, Y. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02) :S129-S130
[92]   Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial [J].
Schoffski, Patrick ;
Chawla, Sant ;
Maki, Robert G. ;
Italiano, Antoine ;
Gelderblom, Hans ;
Choy, Edwin ;
Grignani, Giovanni ;
Camargo, Veridiana ;
Bauer, Sebastian ;
Rha, Sun Young ;
Blay, Jean-Yves ;
Hohenberger, Peter ;
D'Adamo, David ;
Guo, Matthew ;
Chmielowski, Bartosz ;
Le Cesne, Axel ;
Demetri, George D. ;
Patel, Shreyaskumar R. .
LANCET, 2016, 387 (10028) :1629-1637
[93]   Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma Patients [J].
Schroeder, Brett A. ;
Zhang, Yuzheng ;
Smythe, Kimberly S. ;
Desai, Parth ;
Thomas, Anish ;
Viveiros, Pedro ;
Alexiev, Borislav A. ;
Obeidin, Farres ;
Chen, Eleanor Y. ;
Cranmer, Lee D. ;
Wagner, Michael J. ;
Jones, Robin L. ;
Campbell, Jean S. ;
Pierce, Robert H. ;
He, Qianchuan ;
Pollack, Seth M. .
CANCERS, 2022, 14 (05)
[94]   CD4+T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes [J].
Schroeder, Brett A. ;
LaFranzo, Natalie A. ;
LaFleur, Bonnie J. ;
Gittelman, Rachel M. ;
Vignali, Marissa ;
Zhang, Shihong ;
Flanagan, Kevin C. ;
Rytlewski, Julie ;
Riolobos, Laura ;
Schulte, Brian C. ;
Kim, Teresa S. ;
Chen, Eleanor ;
Smythe, Kimberly S. ;
Wagner, Michael J. ;
Mantilla, Jose G. ;
Campbell, Jean S. ;
Pierce, Robert H. ;
Jones, Robin L. ;
Cranmer, Lee D. ;
Pollack, Seth M. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (08)
[95]   Histiocyte predominant myocarditis resulting from the addition of interferon gamma to cyclophosphamide-based lymphodepletion for adoptive cellular therapy [J].
Schroeder, Brett A. ;
Black, Ralph Graeme ;
Spadinger, Sydney ;
Zhang, Shihong ;
Kohli, Karan ;
Cao, Jianhong ;
Mantilla, Jose G. ;
Conrad, Ernest U. ;
Riddell, Stanley R. ;
Jones, Robin L. ;
Yee, Cassian ;
Pollack, Seth M. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
[96]  
SEER*Explorer, 2023, An interactive website for SEER cancer statistics
[97]   Pathologic Response Rates after Neoadjuvant Therapy for Sarcoma: A Single Institution Study [J].
Seldon, Crystal ;
Shrivastava, Gautam ;
Fernandez, Melanie ;
Jarboe, John ;
Conway, Sheila ;
Pretell, Juan ;
Freedman, Laura ;
Wolfson, Aaron ;
Zhao, Wei ;
Kwon, Deukwoo ;
Rosenberg, Andrew ;
Subhawong, Ty ;
Trent, Jonathan ;
Yechieli, Raphael .
CANCERS, 2021, 13 (05) :1-11
[98]   Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma A Phase 1 Nonrandomized Controlled Trial [J].
Seo, Yongwoo David ;
Lu, Hailing ;
Black, Graeme ;
Smythe, Kimberly ;
Yu, Yuexin ;
Hsu, Cynthia ;
Ng, Juliana ;
de Viveiros, Pedro Hermida ;
Warren, E. Houston ;
Schroeder, Brett A. ;
O'Malley, Ryan B. ;
Cranmer, Lee D. ;
Loggers, Elizabeth T. ;
Wagner, Michael J. ;
Bonham, Lynn ;
Pillarisetty, Venu G. ;
Kane, Gabrielle ;
Berglund, Peter ;
Hsu, Frank J. ;
Mi, Xinlei ;
Alexiev, Borislav A. ;
Pierce, Robert H. ;
Riddell, Stanley R. ;
Jones, Robin L. ;
ter Meulen, Jan ;
Kim, Edward Y. ;
Pollack, Seth M. .
JAMA ONCOLOGY, 2023, 9 (12) :1660-1668
[99]   Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2: Tumor and Immunological Responses [J].
Seung, Steven K. ;
Curti, Brendan D. ;
Crittenden, Marka ;
Walker, Edwin ;
Coffey, Todd ;
Siebert, Janet C. ;
Miller, William ;
Payne, Roxanne ;
Glenn, Lyn ;
Bageac, Alexandru ;
Urba, Walter J. .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (137)
[100]   Radiation Therapy in Metastatic Soft Tissue Sarcoma: From Palliation to Ablation [J].
Shah, Nishant K. ;
Yegya-Raman, Nikhil ;
Jones, Joshua A. ;
Shabason, Jacob E. .
CANCERS, 2021, 13 (19)